NYSE : CC
The Chemours Company — Key statistics
Materials · Specialty Chemicals · United States
Last price 13.53 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.04B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.04B |
| Enterprise Value | 5.49B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | Nov 16, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 150.50M |
| Shares Outstanding | 150.50M |
| Shares Change (YoY) | +0.52% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 0.60% |
| Owned by Institutions (%) | 91.62% |
| Float | 149.56M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 9.65 |
| PS Ratio | 0.35 |
| Forward PS | 0.33 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.37 |
| P/OCF Ratio | 5.14 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.95 |
| EV / EBITDA | 11.32 |
| EV / EBIT | 33.09 |
| EV / FCF | 25.19 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.66 |
| Quick Ratio | 0.84 |
| Debt / Equity | n/a |
| Debt / EBITDA | 6.49 |
| Debt / FCF | 18.90 |
| Interest Coverage | 0.61 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -319.37% |
| Return on Assets (ROA) | 1.42% |
| Return on Invested Capital (ROIC) | 3.56% |
| Return on Capital Employed (ROCE) | 3.14% |
| Weighted Average Cost of Capital (WACC) | 7.47% |
| Revenue Per Employee | $1.02M |
| Profits Per Employee | -$53,333 |
| Employee Count | 5,700 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 3.26 |
Taxes
| Measure | Value |
|---|
| Income Tax | 255.00M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.40 |
| 52-Week Price Change | +1.20% |
| 50-Day Moving Average | 14.18 |
| 200-Day Moving Average | 18.39 |
| Relative Strength Index (RSI) | 50.32 |
| Average Volume (20 Days) | 2,150,059 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 14.85M |
| Short Previous Month | 15.74M |
| Short % of Shares Out | 9.87% |
| Short % of Float | 9.93% |
| Short Ratio (days to cover) | 7.07 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 5.80B |
| Gross Profit | 893.00M |
| Operating Income | 166.00M |
| Pretax Income | -50.00M |
| Net Income | -304.00M |
| EBITDA | 485.00M |
| EBIT | 166.00M |
| Loss Per Share | -$2.03 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 671.00M |
| Total Debt | 4.12B |
| Net Cash | -3.45B |
| Net Cash Per Share | -$22.92 |
| Equity (Book Value) | -48.00M |
| Book Value Per Share | -0.33 |
| Working Capital | 1.23B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 397.00M |
| Capital Expenditures | -179.00M |
| Depreciation & Amortization | 319.00M |
| Net Borrowing | -299.00M |
| Free Cash Flow | 218.00M |
| FCF Per Share | $1.45 |
Margins
| Measure | Value |
|---|
| Gross Margin | 15.40% |
| Operating Margin | 2.86% |
| Pretax Margin | -0.86% |
| Profit Margin | -5.24% |
| EBITDA Margin | 8.37% |
| EBIT Margin | 2.86% |
| FCF Margin | 3.76% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.35 |
| Dividend Yield | 2.58% |
| Dividend Growth (YoY) | -31.71% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | 24.16% |
| Buyback Yield | -0.52% |
| Shareholder Yield | 2.07% |
| Earnings Yield | -14.95% |
| FCF Yield | 10.67% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $16.50 |
| Price Target Difference | 21.73% |
| Analyst Consensus | Hold |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 3.49% |
| EPS Growth Forecast (3Y) | 34.34% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.48 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |